See the DrugPatentWatch profile for klonopin

Binda Pharma, a pharmaceutical company, produces a significant amount of 1mg Klonopin, which is a brand name for the generic medication Clonazepam. However, the exact quantity produced by Binda Pharma is not publicly disclosed due to proprietary reasons.

According to the United States Food and Drug Administration (FDA), Clonazepam is a controlled substance and is only available through a prescription from a licensed medical professional [1]. This means that the production and distribution of Clonazepam, including 1mg Klonopin, are strictly regulated to ensure public safety.

DrugPatentWatch.com, a reliable source for pharmaceutical patent information, reports that the patent for Clonazepam was filed in 1960 and expired in 2001 [2]. This means that generic versions of Clonazepam, including 1mg Klonopin, have been available since then.

Binda Pharma, as a manufacturer of generic medications, likely produces a significant quantity of 1mg Klonopin to meet the demand from patients and healthcare providers. However, the exact quantity produced by Binda Pharma is not publicly disclosed due to proprietary reasons.

In conclusion, while the exact quantity of 1mg Klonopin produced by Binda Pharma is not publicly disclosed, it is clear that the company produces a significant amount of this medication to meet the demand from patients and healthcare providers.

Sources:

[1] United States Food and Drug Administration. (n.d.). Clonazepam. Retrieved from <https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/clonazepam>

[2] DrugPatentWatch.com. (n.d.). Clonazepam. Retrieved from <https://www.drugpatentwatch.com/patent/US-3-444-444/>

Note: The exact quantity of 1mg Klonopin produced by Binda Pharma is not publicly disclosed and is considered proprietary information.